212 related articles for article (PubMed ID: 10352302)
21. Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages.
Chelvarajan L; Popa D; Liu Y; Getchell TV; Stromberg AJ; Bondada S
J Leukoc Biol; 2007 Aug; 82(2):403-16. PubMed ID: 17495050
[TBL] [Abstract][Full Text] [Related]
22. Human B cells and macrophages cooperate in T-cell-independent type 2 response.
Mättö M; Raunio AR; Postila V; Huttunen K; Hirvonen MR; Pelkonen J
Scand J Immunol; 2008 Mar; 67(3):209-17. PubMed ID: 18194360
[TBL] [Abstract][Full Text] [Related]
23. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
Walker TM; Burger CJ; Elgert KD
Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
[TBL] [Abstract][Full Text] [Related]
24. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
[TBL] [Abstract][Full Text] [Related]
25. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
26. Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression.
Bhat N; Perera PY; Carboni JM; Blanco J; Golenbock DT; Mayadas TN; Vogel SN
J Immunol; 1999 Jun; 162(12):7335-42. PubMed ID: 10358184
[TBL] [Abstract][Full Text] [Related]
27. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function.
Chelvarajan RL; Collins SM; Van Willigen JM; Bondada S
J Leukoc Biol; 2005 Apr; 77(4):503-12. PubMed ID: 15629885
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of interleukin 1 production by macrophages of sarcoma-bearing mice.
Moldawer LL; Lonnroth C; Mizel SB; Lundholm KG
J Immunol; 1987 Jun; 138(12):4270-4. PubMed ID: 3495587
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
[TBL] [Abstract][Full Text] [Related]
30. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
[TBL] [Abstract][Full Text] [Related]
31. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages.
Ramos-Ligonio A; López-Monteon A; Talamás-Rohana P; Rosales-Encina JL
Parasite Immunol; 2004 Oct; 26(10):409-18. PubMed ID: 15752118
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-4 regulates macrophage interleukin-12 protein synthesis through a c-fos mediated mechanism.
Roy S; Charboneau R; Melnyk D; Barke RA
Surgery; 2000 Aug; 128(2):219-24. PubMed ID: 10922995
[TBL] [Abstract][Full Text] [Related]
33. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.
Mullins DW; Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1997 Aug; 37(1):63-73. PubMed ID: 9285245
[TBL] [Abstract][Full Text] [Related]
34. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.
Huang B; Pan PY; Li Q; Sato AI; Levy DE; Bromberg J; Divino CM; Chen SH
Cancer Res; 2006 Jan; 66(2):1123-31. PubMed ID: 16424049
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous aberrations in Mphi and T cell function adversely affect trauma patients' clinical outcome: a possible faulty IL-13 feedback loop.
Laudanski K; De A; Pellegrini J; Miller-Graziano C
Clin Immunol; 2006; 118(2-3):332-41. PubMed ID: 16303333
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice.
Gao Y; Gao H; Chan E; Tang W; Xu A; Yang H; Huang M; Lan J; Li X; Duan W; Xu C; Zhou S
Immunol Invest; 2005; 34(2):171-98. PubMed ID: 15921158
[TBL] [Abstract][Full Text] [Related]
37. Tumor-induced variations in a high molecular weight inhibitory monokine.
Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
[TBL] [Abstract][Full Text] [Related]
38. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
39. TLR agonists that induce IFN-beta abrogate resident macrophage suppression of T cells.
Hamilton MJ; Antignano F; von Rossum A; Boucher JL; Bennewith KL; Krystal G
J Immunol; 2010 Oct; 185(8):4545-53. PubMed ID: 20844190
[TBL] [Abstract][Full Text] [Related]
40. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]